Hyperlipidemias Clinical Trial
Official title:
Hyperlipidemia Therapy in tERtiary Cardiological cEnTer Zabrze Registry
A study conducted to evaluate the efficacy of lipid-lowering therapy in patients with high
and very high risk treated by interventional cardiology. Study endpoints:
1. Achievement of the target LDL-C at 1-year follow-up LDL-C <70 mg / dl in the group of
very high-risk and LDL-C <100 mg / dL in high-risk patients
2. Assessment of the lipid profile of the severity of coronary artery disease in patients
undergoing invasive diagnosis of coronary artery disease
3. Evaluation of trends in the treatment of lipid-lowering in patients in different years
The TERCET Zabrze Registry is an observational study of all patients hospitalized due to the
cardiovascular diseases. The date include information on the hyperlipidaemia treatment,
clinical characteristics, any treatment modalities and prognosis in this population. Data
collection is patient-based (not event-based).
The study population is formed by all-comer patients hospitalized in cardiology wards and
intensive cardiac care units with a diagnosis of coronary disease, both stable angina, and
acute coronary syndromes (ACS). For the purpose of this study hyperlipidaemia is defined in
accordance with European Society of Cardiology guidelines.
Complete patient demographics; medical history, complete hospitalization data (diagnostic
and therapeutic), in-hospital and out-hospital results are collected in an electronic form
by the attending physician. The patients are under constant follow-up for all cause
mortality and major adverse events.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03793985 -
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
|
Phase 1 | |
| Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Completed |
NCT04516291 -
A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
|
Phase 2 | |
| Completed |
NCT03632668 -
Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
|
Phase 1 | |
| Completed |
NCT04701775 -
Effect of Different Probiotic Strains in Hypercholesterolemic Patients
|
N/A | |
| Completed |
NCT03534661 -
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
|
Phase 2/Phase 3 | |
| Completed |
NCT03422666 -
Plasma Lipoprotein Response to Glucagon-like Peptide-2
|
Phase 2/Phase 3 | |
| Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
| Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
| Recruiting |
NCT04560296 -
Community-based E-Health Program for Older Adults Living With Chronic Diseases
|
N/A | |
| Terminated |
NCT04073134 -
The CHORAL Flow Study
|
Phase 4 | |
| Recruiting |
NCT05103254 -
Bempedoic Acid Pregnancy Surveillance Program
|
||
| Not yet recruiting |
NCT05015348 -
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia
|
N/A | |
| Active, not recruiting |
NCT05082350 -
Nutritional Intervention With Black Garlic
|
N/A | |
| Not yet recruiting |
NCT04398771 -
To Evaluate Safety and Effectiveness of RovatitanTab.
|
||
| Not yet recruiting |
NCT04064281 -
The Healthy Cantonese Diet on Cardiometabolic Syndrome
|
N/A | |
| Recruiting |
NCT06257641 -
Impact of the Mediterranean Diet on Patients With Psoriasis
|
N/A | |
| Completed |
NCT03690778 -
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
|
Phase 1 | |
| Completed |
NCT04354987 -
Compare the Pharmacokinetics and Safety of CKD-391
|
Phase 1 |